Insiders · Profile

Greene Barry E

President at ALNYLAM PHARMACEUTICALS · Director at Karyopharm Therapeutics. Filing since 31 Oct 2006. CIK 0001291963

Company
Date
Role
Action
Shares
Amount
Of holding
9 Sep 2020
President
Sold, plan not stated
44,530
$5.49M
38.8%
7 Jul 2020
President
Sold, plan not stated
22,265
$3.56M
26.3%
6 May 2020
President
Sold, plan not stated
22,265
$3.34M
26.3%
22 Oct 2019
President
Sold, plan not stated
58,913
$5.30M
52.7%
14 Mar 2018
President
Sold, plan not stated
38,460
$5.50M
38.3%
2 Oct 2017
President
Sold, plan not stated
85,316
$10.66M
45.9%
20 Sep 2017
President
Sold, plan not stated
76,815
$7.68M
46.4%
1 Dec 2016
President
Sold, plan not stated
31,825
$1.37M
26.4%
26 May 2015
President and COO
Sold, plan not stated
67,379
$8.42M
74.2%
2 Apr 2015
Director
Bought
3,000
$87.94K
opened
19 Dec 2014
President and COO
Sold, plan not stated
11,200
$1.12M
33.3%
17 Nov 2014
President and COO
Sold, plan not stated
33,200
$2.98M
49.7%
11 Nov 2014
President and COO
Sold, plan not stated
11,100
$1.11M
24.8%
28 May 2013
President and COO
Sold, plan not stated
22,822
$684.66K
83.3%
14 Mar 2013
President & COO
Sold, plan not stated
24,058
$601.45K
84.0%
8 Mar 2013
President and COO
Sold, plan not stated
24,000
$586.27K
84.0%
21 Feb 2012
President and COO
Bought
1,860
$20.00K
68.6%
9 Jan 2012
President and COO
Bought
567
$4.99K
26.4%
12 Dec 2011
President and COO
Bought
699
$5.00K
48.3%
14 Nov 2011
President and COO
Bought
704
$4.99K
94.9%
11 Oct 2011
President and COO
Bought
742
$5.00K
opened
13 Aug 2008
President and COO
Sold, plan not stated
35,440
$1.20M
100%
24 Oct 2007
COO
Sold, plan not stated
37,500
$1.16M
89.2%
31 Oct 2006
COO and Treasurer
Sold, plan not stated
12,500
$258.88K
22.9%
24 decisions on file.